Abstract:Objective To investigate the effects and the underlying mechanism of the glucagons-like peptide 2 (GLP-2) on the intestinal mucosal proliferation after ischemia /reperfusion insult in a mouse model. Methods Thirty ICR male mice were randomly divided into three groups: normal control (N),control (C) and GLP-2 treatment (T). Ischemic injury was induced by ligating the superior mesenteric artery in group C and group T. Mice in group T were injected subcutaneously with GLP-2,while mice in group C were injected subcutaneously with PBS. On the 5th postoperative day,the morphological changes of jejunum and ileum were examined,the expression of proliferating cell nuclear antigen (PCNA) and the cell apoptosis (INST) were assayed. Results The villous height,crypt depth and mucosal thickness of the ileum in group T were significantly higher than those in group C and group N (P0.05). The crypt PCNA positive index in group T was significantly higher than that of group C (P0.05). The enterocyte apoptosis in group T was significantly lower than that in group C (P0.01). Conclusion GLP-2 could enhance small bowel morphological proliferation by stimulating the enterocyte proliferation and decreasing the enterocyte apoptosis in a mouse model of ischemia /reperfusion insult.

Effects of GLP-2 on Mouse Intestinal Mucosal Proliferation after Ischemia/reperfusion Insult